Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-006126
Filing Date
2012-11-14
Accepted
2012-11-14 16:29:54
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 c71572_10-q.htm 10-Q 268274
2 c71572_ex31-1.htm EX-31.1 8520
3 c71572_ex31-2.htm EX-31.2 8732
4 c71572_ex32-1.htm EX-32.1 3384
5 c71572_ex32-2.htm EX-32.2 3397
  Complete submission text file 0000930413-12-006126.txt   3365677

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ibio-20120930.xml EX-101.INS 684470
7 XBRL SCHEMA FILE ibio-20120930.xsd EX-101.SCH 29868
8 XBRL CALCULATION FILE ibio-20120930_cal.xml EX-101.CAL 13338
9 XBRL DEFINITION FILE ibio-20120930_def.xml EX-101.DEF 147705
10 XBRL LABEL FILE ibio-20120930_lab.xml EX-101.LAB 208505
11 XBRL PRESENTATION FILE ibio-20120930_pre.xml EX-101.PRE 151393
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 121205087
SIC: 2834 Pharmaceutical Preparations